XCS7:XETRA:XETRA-Xtrackers MSCI China UCITS ETF 1D EUR (EUR)

ETF | Others |

Last Closing

USD 6.291

Change

+0.15 (+2.48)%

Market Cap

N/A

Volume

1.64K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.17 (+2.33%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.38 (+2.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.62 (+2.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.63 (+2.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.66 (+2.76%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+3.78 (+2.75%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.79 (+1.74%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.15 (+2.31%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.54 (+1.22%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.43 (+1.90%)

USD 79.79B

ETFs Containing XCS7:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.80% 29% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.80% 28% F 33% F
Trailing 12 Months  
Capital Gain -4.54% 10% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.54% 10% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -5.67% 8% B- 11% F
Dividend Return -5.67% 7% C- 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.01% 63% D 71% C-
Risk Adjusted Return -62.99% 10% F 10% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.